Recent advances in MR imaging for cancer diagnosis

Koji Sagiyama, Yuji Watanabe, Akihiro Nishie, Ryotaro Kamei, Osamu Togao, Hiwatashi Akio, Satoshi Kawanami, Hiroshi Honda

研究成果: ジャーナルへの寄稿評論記事

2 引用 (Scopus)

抄録

The recent development in magnetic resonance (MR) hardware and techniques allows the acquisition of functional information, such as perfusion or metabolism, in addition to conventional anatomical information in of cancers. In this review article, various molecular imaging methods based on MR are introduced and their application and usefulness for diagnosis of cancer are discussed. Diffusion weighted image (DWI) is believed to correlate cell density and reflect malignancy of tumor DWI has been widely used for the diagnosis and evaluation of responses to cancer treatment. Arterial spin labeling (ASL) allows acquisition of perfusion data without the use of any contrast agent and is expected to be an alternative or complementary method to dynamic contrast enhanced MR imaging. Amide proton transfer (APT) imaging reflects the amount of mobile peptide and proteins in cancer tissue, and could be a useful tool for assessing tumor malignancy or evaluating treatment responses. More specific measurement of cancer metabolites is available at the cost of spatial resolution by MR spectroscopy (MRS). Finally, the positron emission tomography (PET)/MR hybrid system enables simultaneous acquisition of functional/ anatomical information from MR imaging and molecular/metabolic information from PET imaging. Combining various molecular MR imaging methods with PET tracers may have a huge potential for clinical diagnosis of cancer.

元の言語英語
ページ(範囲)257-260
ページ数4
ジャーナルJapanese Journal of Cancer and Chemotherapy
42
発行部数3
出版物ステータス出版済み - 1 1 2015

Fingerprint

Magnetic Resonance Imaging
Neoplasms
Magnetic Resonance Spectroscopy
Positron-Emission Tomography
Perfusion
Molecular Imaging
Amides
Contrast Media
Protons
Cell Count
Peptides
Proteins

All Science Journal Classification (ASJC) codes

  • Medicine(all)

これを引用

Recent advances in MR imaging for cancer diagnosis. / Sagiyama, Koji; Watanabe, Yuji; Nishie, Akihiro; Kamei, Ryotaro; Togao, Osamu; Akio, Hiwatashi; Kawanami, Satoshi; Honda, Hiroshi.

:: Japanese Journal of Cancer and Chemotherapy, 巻 42, 番号 3, 01.01.2015, p. 257-260.

研究成果: ジャーナルへの寄稿評論記事

Sagiyama, K, Watanabe, Y, Nishie, A, Kamei, R, Togao, O, Akio, H, Kawanami, S & Honda, H 2015, 'Recent advances in MR imaging for cancer diagnosis', Japanese Journal of Cancer and Chemotherapy, 巻. 42, 番号 3, pp. 257-260.
Sagiyama, Koji ; Watanabe, Yuji ; Nishie, Akihiro ; Kamei, Ryotaro ; Togao, Osamu ; Akio, Hiwatashi ; Kawanami, Satoshi ; Honda, Hiroshi. / Recent advances in MR imaging for cancer diagnosis. :: Japanese Journal of Cancer and Chemotherapy. 2015 ; 巻 42, 番号 3. pp. 257-260.
@article{16404a967fb74da4af512b21b1b18fcf,
title = "Recent advances in MR imaging for cancer diagnosis",
abstract = "The recent development in magnetic resonance (MR) hardware and techniques allows the acquisition of functional information, such as perfusion or metabolism, in addition to conventional anatomical information in of cancers. In this review article, various molecular imaging methods based on MR are introduced and their application and usefulness for diagnosis of cancer are discussed. Diffusion weighted image (DWI) is believed to correlate cell density and reflect malignancy of tumor DWI has been widely used for the diagnosis and evaluation of responses to cancer treatment. Arterial spin labeling (ASL) allows acquisition of perfusion data without the use of any contrast agent and is expected to be an alternative or complementary method to dynamic contrast enhanced MR imaging. Amide proton transfer (APT) imaging reflects the amount of mobile peptide and proteins in cancer tissue, and could be a useful tool for assessing tumor malignancy or evaluating treatment responses. More specific measurement of cancer metabolites is available at the cost of spatial resolution by MR spectroscopy (MRS). Finally, the positron emission tomography (PET)/MR hybrid system enables simultaneous acquisition of functional/ anatomical information from MR imaging and molecular/metabolic information from PET imaging. Combining various molecular MR imaging methods with PET tracers may have a huge potential for clinical diagnosis of cancer.",
author = "Koji Sagiyama and Yuji Watanabe and Akihiro Nishie and Ryotaro Kamei and Osamu Togao and Hiwatashi Akio and Satoshi Kawanami and Hiroshi Honda",
year = "2015",
month = "1",
day = "1",
language = "English",
volume = "42",
pages = "257--260",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "3",

}

TY - JOUR

T1 - Recent advances in MR imaging for cancer diagnosis

AU - Sagiyama, Koji

AU - Watanabe, Yuji

AU - Nishie, Akihiro

AU - Kamei, Ryotaro

AU - Togao, Osamu

AU - Akio, Hiwatashi

AU - Kawanami, Satoshi

AU - Honda, Hiroshi

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The recent development in magnetic resonance (MR) hardware and techniques allows the acquisition of functional information, such as perfusion or metabolism, in addition to conventional anatomical information in of cancers. In this review article, various molecular imaging methods based on MR are introduced and their application and usefulness for diagnosis of cancer are discussed. Diffusion weighted image (DWI) is believed to correlate cell density and reflect malignancy of tumor DWI has been widely used for the diagnosis and evaluation of responses to cancer treatment. Arterial spin labeling (ASL) allows acquisition of perfusion data without the use of any contrast agent and is expected to be an alternative or complementary method to dynamic contrast enhanced MR imaging. Amide proton transfer (APT) imaging reflects the amount of mobile peptide and proteins in cancer tissue, and could be a useful tool for assessing tumor malignancy or evaluating treatment responses. More specific measurement of cancer metabolites is available at the cost of spatial resolution by MR spectroscopy (MRS). Finally, the positron emission tomography (PET)/MR hybrid system enables simultaneous acquisition of functional/ anatomical information from MR imaging and molecular/metabolic information from PET imaging. Combining various molecular MR imaging methods with PET tracers may have a huge potential for clinical diagnosis of cancer.

AB - The recent development in magnetic resonance (MR) hardware and techniques allows the acquisition of functional information, such as perfusion or metabolism, in addition to conventional anatomical information in of cancers. In this review article, various molecular imaging methods based on MR are introduced and their application and usefulness for diagnosis of cancer are discussed. Diffusion weighted image (DWI) is believed to correlate cell density and reflect malignancy of tumor DWI has been widely used for the diagnosis and evaluation of responses to cancer treatment. Arterial spin labeling (ASL) allows acquisition of perfusion data without the use of any contrast agent and is expected to be an alternative or complementary method to dynamic contrast enhanced MR imaging. Amide proton transfer (APT) imaging reflects the amount of mobile peptide and proteins in cancer tissue, and could be a useful tool for assessing tumor malignancy or evaluating treatment responses. More specific measurement of cancer metabolites is available at the cost of spatial resolution by MR spectroscopy (MRS). Finally, the positron emission tomography (PET)/MR hybrid system enables simultaneous acquisition of functional/ anatomical information from MR imaging and molecular/metabolic information from PET imaging. Combining various molecular MR imaging methods with PET tracers may have a huge potential for clinical diagnosis of cancer.

UR - http://www.scopus.com/inward/record.url?scp=84931094308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931094308&partnerID=8YFLogxK

M3 - Review article

C2 - 25812492

AN - SCOPUS:84931094308

VL - 42

SP - 257

EP - 260

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 3

ER -